TIERED COST SHARING
Access to treatment initiative enables treatment costs to be shared between the patient, the pharmaceutical company, and potentially other parties, based on a patient’s ability to pay. Unlike bonus schemes, cost sharing enables patients to access their full course of treatment, and in turn, maximize their medical outcomes. ON-TIME ACCESS
Provided as a complementing support to patients in the existing Patient Assistance Programs (PAPs), On-Time Access increases the financial sustainability of the program allowing patients to access specialty medications or high-value innovative treatments they need to initiate or continue their treatment right on-time! CO-PAY SUPPORT
For patients who are partially reimbursed, some still struggle to cover the non-reimbursed co-pay for their medication. By supporting these patients by covering their co-pay via voucher, they are able to complete their full course of treatment as prescribed.ADDITIONAL MODELS
The above are examples of innovative access models used by Axios. At the stage of strategy development, the specific needs of a given patient group, country, product and disease area are considered to design customized access models to close the identified gaps. 
